Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)
TWD 27.9
(-0.18%)
TWD 27.9
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.06 Billion | 1.14 Billion | 1.02 Billion | 979.35 Million | 1.02 Billion |
| Cost of Revenue | 717.76 Million | 720.56 Million | 665.71 Million | 656.43 Million | 682.75 Million |
| Gross Profit | 343.1 Million | 422.5 Million | 356.57 Million | 322.92 Million | 340.19 Million |
| Operating Expenses | 281.88 Million | 268.67 Million | 237.52 Million | 247.36 Million | 252.98 Million |
| Selling, General and Administrative Expenses | 234.86 Million | 248.98 Million | 218.58 Million | 229.15 Million | 232.34 Million |
| Research and Development Expenses | 21.66 Million | 19.68 Million | 18.93 Million | 18.21 Million | 20.63 Million |
| Other Expenses | - | 8.61 Million | 13.39 Million | 4.3 Million | 8.96 Million |
| Cost and Expenses | 999.65 Million | 989.24 Million | 903.23 Million | 903.79 Million | 935.74 Million |
| Operating Income | 61.21 Million | 163.8 Million | 132.87 Million | 81.59 Million | 97.47 Million |
| Interest Expense | - | 1.52 Million | 1.09 Million | 162 Thousand | 263 Thousand |
| Income Tax Expense | 18.65 Million | -16.99 Million | 24.07 Million | 22.28 Million | 24.8 Million |
| Earnings before Tax | 87.33 Million | 162.28 Million | 131.77 Million | 81.42 Million | 97.25 Million |
| Net Income | 68.67 Million | 154 Million | 80.75 Million | 59.14 Million | 72.45 Million |
| Earnings Per Share Basic | 1.21 | 2.70 | 1.42 | 1.04 | 1.27 |
| Earnings Per Share Diluted | 1.20 | 2.69 | 1.41 | 1.03 | 1.27 |
| Weighted Average Shares Outstanding | 56.98 Million | 56.98 Million | 56.98 Million | 56.98 Million | 56.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.22 Million | 57.31 Million | 57.27 Million | 57.22 Million | 57.22 Million |
| Gross Margin | 0.32 | 0.37 | 0.35 | 0.33 | 0.33 |
| EBIT Margin | 0.11 | 0.21 | 0.21 | 0.17 | 0.18 |
| Profit Margin | 0.06 | 0.13 | 0.08 | 0.06 | 0.07 |
| EBITDA | 117.55 Million | 225.2 Million | 197.48 Million | 164.58 Million | 178.91 Million |
| Earnings Before Tax Margin | 0.06 | 0.14 | 0.13 | 0.08 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 282.51 Million | 267.2 Million | 269.95 Million | 261.87 Million | 265.87 Million | 263.16 Million |
| Cost of Revenue | 190.84 Million | 185.81 Million | 182.02 Million | 182.23 Million | 180.22 Million | 173.28 Million |
| Gross Profit | 91.67 Million | 81.38 Million | 87.93 Million | 79.64 Million | 85.64 Million | 89.88 Million |
| Operating Expenses | 74.92 Million | 69.96 Million | 68.04 Million | 72.9 Million | 72.23 Million | 68.7 Million |
| Selling, General and Administrative Expenses | 70.13 Million | 65.19 Million | 63.22 Million | 67.26 Million | 66.31 Million | 63.41 Million |
| Research and Development Expenses | 4.79 Million | 4.76 Million | 4.82 Million | 5.63 Million | 5.92 Million | 5.28 Million |
| Other Expenses | 5.48 Million | 13.2 Million | - | 16.77 Million | 8.79 Million | -725 Thousand |
| Cost and Expenses | 265.77 Million | 255.78 Million | 250.06 Million | 255.13 Million | 252.46 Million | 241.98 Million |
| Operating Income | 26.33 Million | 28.63 Million | 19.88 Million | 27.05 Million | 25.95 Million | 23.78 Million |
| Interest Expense | 579 Thousand | 502 Thousand | - | 294 Thousand | 279 Thousand | 380 Thousand |
| Income Tax Expense | 5.15 Million | 4.99 Million | 3.92 Million | 4.91 Million | 5.13 Million | 4.68 Million |
| Earnings before Tax | 25.75 Million | 28.12 Million | 11.48 Million | 26.75 Million | 25.67 Million | 23.4 Million |
| Net Income | 20.6 Million | 23.12 Million | 7.56 Million | 21.84 Million | 20.54 Million | 18.71 Million |
| Earnings Per Share Basic | 0.36 | 0.41 | 0.13 | 0.38 | 0.36 | 0.33 |
| Earnings Per Share Diluted | 0.36 | 0.40 | 0.13 | 0.38 | 0.36 | 0.33 |
| Weighted Average Shares Outstanding | 57.23 Million | 56.4 Million | 58.22 Million | 57.48 Million | 57.06 Million | 56.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.23 Million | 57.82 Million | 57.22 Million | 57.48 Million | 57.06 Million | 56.72 Million |
| Gross Margin | 0.32 | 0.30 | 0.33 | 0.30 | 0.32 | 0.34 |
| EBIT Margin | 0.15 | 0.17 | 0.11 | 0.16 | 0.16 | 0.15 |
| Profit Margin | 0.07 | 0.09 | 0.03 | 0.08 | 0.08 | 0.07 |
| EBITDA | 42.62 Million | 45.43 Million | 30.37 Million | 42.15 Million | 41.36 Million | 39.13 Million |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.07 | 0.10 | 0.10 | 0.09 |
WINA
PHIA
IBT-B
OBGRF
BRM
JMFINANCIL